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1. Introduction 
Repolarization alternans (RA), an electrophysiologic phenomenon consisting on every-
other-beat changes of the repolarization morphology (amplitude, shape, and, sometimes, 
polarity) unaccompanied by gross changes in the heart-cycle length, is generally recognized 
as a promising electrocardiographic (ECG) predictor of sudden cardiac arrest (SCA; 
Bloomfield et al., 2006, Chow et al. 2006, Ikeda et al., 2006, Klingenheben et al., 2000, Leino et 
al., 2009, Maeda et al., 2009, Narayan, 2006, Rosenbaum et al., 1994, Sakaki et al., 2009, 
Salerno-Uriarte et al., 2007, Stein et al., 2008), that is one of the leading causes of death in 
developed countries (over 300,000 lives per year in the U.S.; Montagnana at al., 2008, Zheng 
et al., 2001). On the ECG tracing, RA consists of an alternation of either the ST-segment 
(Nearing et al., 1991, Rosenbaum et al., 1994), or the T-wave, or even the U-wave (Habbab & 
el-Sherif, 1992). Macroscopic and, thus, visible RA (like that reported in Fig. 1) is quite rare. 
After being first reported by Hering in the early 1900s (Hering, 1909), RA has later on been 
occasionally observed in patients affected by various diseases, among which ischemia 
(Kleinfeld & Rozanski, 1977), long QT syndrome (Schwartz & Malliani, 1975, Zareba et al., 
1994) and ventricular arrhythmias (Verrier et al., 2003). Recent investigations on RA rely on 
automatic detection of microvolt RA from the digital ECG signal by means of specifically 
designed techniques, among which the spectral method (implemented in the commercial 
ECG machine CH2000 and Heartwave, Cambridge Heart Inc., Bedford, MA; Smith et al., 
1988, Rosenbaum et al., 1994, Rosenbaum et al., 1996), the complex demodulation method 
(Nearing et al., 1991, Nearing & Verrier, 1993), the modified moving average method 
(implemented in the commercial ECG machine CASE-8000, GE Medical Systems, 
Milwaukee, WI; Nearing & Verrier, 2002), the Laplacian likelihood ratio method (Martínez 
& Olmos, 2005, Martínez et al., 2006), our adaptive match filter method (Burattini et al., 
2008, Burattini et al., 2009b) and others (Burattini et al., 1999, Martínez & Olmos, 2005). 
Microvolt RA has been found to be much more common than visible RA (Adachi et al., 1999, 
Chow et al., 2007, Ikeda et al., 2006, Klingenheben et al., 2000, Narayan et al., 2006, Narayan 
et al., 2007, Reddy et al., 1984) and linked to inducible (Narayan and Smith, 2000, 
Rosenbaum et al., 1994, Smith et al., 1988) as well as spontaneous (Bloomfield et al., 2006, 
Klingenheben et al., 2000, Maeda et al., 2009, Narayan, 2006, Verrier et al., 2003) ventricular 
arrhythmias.  
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The pathophysiology underlying microvolt RA in humans has not been delineated yet. 
Several experimental settings have shown that RA may reflect spatial (Banville & Gray, 
2002, Chinushi et al., 1998, Narayan, 2006) or temporal (Narayan, 2006, Pastore et al., 1999) 
dispersion of repolarization, both preceding ventricular fibrillation (Weiss et al., 1999, Smith 
& Cohen, 1984). Indeed, spatial variations in repolarization (action potential duration, APD) 
or conduction velocity may prevent depolarization in myocytes that are still repolarizing 
from their last cycle, causing the typical 2:1 behavior (Banville & Gray, 2002, Chinushi et al., 
1998). RA may also results from an alternation of the APD (temporal dispersion of 
repolarization), which can occur when the relationship of the APD to its preceding diastolic 
interval (i.e. the APD restitution curve) has a slope greater than one. Under these conditions, 
mainly occurring in the presence of fast heart rates, small changes of the diastolic interval 
may cause large APD fluctuations that facilitate alternans (Pastore et al., 1999).  
 
Fig. 1. ECG tracing affected by macroscopic RA. 
Alternans derived from the cardiac spatial and temporal dispersion of repolarization 
projects onto body-surface ECG RA, which shows (Selvaraj et al., 2007) an heterogeneous 
temporal location along the JT segment, constituted by the ST-segment and T-wave 
complex. Characterization of this heterogeneity is a matter of major interest, since 
controversial results have been reported after attempting to identify an association of RA to 
different diseases. According to Narayan & Smith (Narayan & Smith, 1999) RA has been 
found to be more specific for inducible ventricular tachycardia when distributed late, rather 
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than elsewhere, throughout the JT segment. In other studies (Martínez et al., 2006, Nearing 
et al., 1994) RA has been found to be located within the ST segment and the first half of the T 
wave in patients undergoing left anterior descending artery occlusion (LAD) and left 
circumflex artery occlusion (LCX), and to occur a little further on along the JT segment in 
patients undergoing right coronary artery occlusion (RCA). Eventually, RA heterogeneity 
along the entire JT segment has been observed in patients with cardiomyopathy (Selvaraj et 
al., 2007). To the best of our knowledge, quantitative investigations on RA location along the 
repolarization segment in the coronary artery disease have not been reported yet. Such an 
investigation was the aim of the present study. 
Considering that our adaptive match filter (AMF) based method has been successfully used 
in previous clinical (Burattini et al., 2008, Burattini et al., 2009a, Burattini et al., 2010) and 
simulation (Burattini et al., 2006, Burattini et al., 2009b, Burattini et al., 2011) studies for 
characterization of T-wave alternans (which can be considered a special case of RA limited 
to the T-wave), this method was applied in the present study to Holter ECGs recordings 
from coronary artery disease (CAD) patients and control healthy (CH) subjects in order to: 
A) automatically identify and quantitatively characterize RA in terms of both amplitude and 
location with respect to the T-wave apex; and B) define a physiological RA region which 
allows discrimination of abnormal (RA+) from normal RA cases. 
2. Methods 
2.1 Study populations and clinical data 
Our clinical data belong to the Intercity Digital Electrocardiology Alliance (IDEAL) Study 
databases, available at the Telemetric and Holter ECG Warehouse database (http://thew-
project.org). The IDEAL protocol was approved by the Research Subject Review Board of 
the University of Rochester (Rochester, NY) and the study was conducted following 
required rules for human subjects’ research principles, according to the Declaration of 
Helsinki, as well as to Title 45, U.S. Code of Federal Regulations, Part 46, Protection of 
Human Subjects, Revised November 13, 2001, effective December 13, 2001.  
Two populations were considered, which consist of 201 coronary artery disease (CAD; 166 
men) patients and 167 control-healthy (CH; 86 men) subjects, respectively. Namely, a patient 
was classified as belonging to the CAD-group if: 
1. having positive angiogram (at least one vessel with critical narrowing >75%) with either 
exercise induced ischemia on ECG or evidence of previous myocardial infarction;  
2. being in stable phase of the ischemic heart disease with digital ECG recordings 
performed on an outpatients basis. Stable post-MI patients should be enrolled at least 2 
month after the index event;  
3. not having evidence of congenital heart failure. Patients with clinical or echocardiographic 
evidence for congestive heart failure (LVD >60 mm, EF <40%) were excluded;  
4. being in sinus rhythm (no atrial flutter/fibrillation, no pacemaker rhythm, no 
atrioventricular block, no sick sinus syndrome); 
5. not having dilated cardiomyopathy (left ventricular diameter >60 mm and ejection 
fraction <40%);  
6. not having coronary instability (unstable angina requiring hospitalization with evolving 
ischemic changes in standard ECG);  
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7. not having congestive heart failure (left ventricular diameter >60 mm and ejection 
fraction <40%);  
8. not having had coronary artery bypass surgery (CABG) in the past. Patients with a 
history of non-CABG coronary revascularization (percutaneous transluminal coronary 
angioplasty, stent, atherectomy) were eligible to be enrolled;  
9. not having major comorbidity such as malignancy, severe haptic, renal or cerebral 
disease.  
Instead, a subject was classified as belonging to the CH-group when fulfilling the following 
criteria: 
1. not having overt cardiovascular disease or history of cardiovascular disorders 
(including stroke, transient ischemic attack, and peripheral vascular disease);  
2. no having history of high blood pressure (>150/90 mmHg);  
3. not taking medication;  
4. not being affected by other chronic illness (e.g. diabetes, asthma, chronic obstructive 
pulmonary disease, etc.);  
5. being diagnosed as being healthy if evaluated by a physician for cardiovascular-related 
syndrome (chest pain, palpitation, syncope); 
6. having normal physical examination;  
7. having sinus rhythm in 12-lead ECG without any suspicious abnormalities (e.g. signs of 
ventricular hypertrophy, inverted T-wave, intraventricular conduction disturbances);  
8. having normal echo and normal ECG exercise testing in presence of suspicious ECG 
changes;  
9. not being pregnant. 
Clinical parameters such as age, body max index (BMI), systolic (SAP) and diastolic (DAP) 
arterial pressure were measured in each subject, whereas the ventricular ejection fraction 
(LVEF, in %) was determined only for the CAD patients. Therapeutic treatments were also 
reported. In addition, a 20-minute, 3-lead (pseudo-orthogonal configuration, with bipolar 
leads X, Y, Z corresponding to limb lead I, augmented limb lead aVF, and precordial lead 
V3, respectively) digital Holter ECG recording was obtained from each individual in supine 
and resting conditions, making use of Burdick recorders (Burdick Inc., Milton, WI; sampling 
frequency: 200 Hz, resolution: 10 µV). ECG tracings were used to determine the heart rate 
(mRR; computed as the mean time interval RR between two consecutive sinus beats in a 5-
min window) and heart-rate variability (sdRR; determined as the standard deviation of the 
RR intervals in a 5-min window) as well as RA parameters (see below).  
2.2 RA identification and characterization  
Repolarization alternans (RA) was identified in the first 5 minutes of each ECG recording. 
More specifically, ECG segments consisting of 16 consecutive heart beats were recursively 
(every 2 s) submitted to a preprocessing stage performing noise removal, R-peak detection, 
baseline removal and identification, and replacement of ectopic or noisy beats (Burattini et 
al., 2006, Martínez. & Olmos, 2005), before being processed by our heart-rate adaptive match 
filter for RA identification (see below). Only 16-beat ECG strings characterized by a stable 
heart rate (RR-interval standard deviation less than 10% mean RR interval) and by the 
presence of a low level of noise or ectopic beats (no more than 1 replaced beats in each ECG 
string) were considered eligible for the subsequent RA analysis.  
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In the presence of a fixed heart rate (and, thus, of a constant time-interval RR between two 
consecutive sinus beats) RA is, by definition, characterized by a specific frequency of half 
heart rate: fRA=0.5 cycles per beat, or fRA= 1/(2×RR) Hz. In clinical cases in which heart rate 
may be considered stable but presenting some physiological variation, the RA phenomenon 
is assumed to be characterized by a narrow frequency band, 2×dfRA wide, centered around 
fRA= 1/(2×meanRR) (Fig. 2; Burattini et al., 2006, Burattini et al., 2008, Burattini et al., 2009a, 
Burattini et al., 2010). On this basis, our AMF is designed as a pass-band filter with its 
passing band centered in fRA (Burattini et al., 2006, Burattini et al., 2008).  
Technically, the AMF is implemented as a 6th order bidirectional Butterworth band-pass 
filter having the passing band 0.12 Hz wide (i.e. dfRA=0.06 Hz) and centered at a frequency 
that adapts to mean RR interval. More specifically, our AMF is a cascade of a low-pass filter 
(LPF) with cut-off frequency fLPF= fRA+ dfRA, and a high-pass filter (HPF) with a cut-off 
frequency fHPF= fRA-dfRA. The squared module of the AMF transfer function is expressed by 
the following equation: 
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Being the AMF applied in a bidirectional fashion, no group delay occurs. Thus, the AMF is 
expected to detect RA by filtering out noise as well as every other ECG component but the 
RA typical one.  
The input signal of the AMF is the 16-beat ECG tracing over which fRA has been computed. 
In the absence of RA, the output of the AMF, called RA signal (Fig. 2), is a zero constant 
signal. Instead, in the presence of RA, the RA signal is a sinusoidal signal, possibly 
amplitude-modulated, characterized by the same length of the ECG and by a frequency 
equal to fRA. 
The time occurrences of the sinusoid maxima or minima, which are expected to fall inside 
the JT intervals when pertaining to RA, provide the center of mass of the alternations in each 
beat, and, thus, a localization of the alternans inside the repolarization (Fig. 3). After having 
identified a reference point (Tref), inside the repolarization segment, as the T-wave apex for 
monophasic T waves, or as the amplitude-weighted mean point between T apexes for 
biphasic T waves, an RA delay (RAD, in ms) parameter was computed, for each beat, as the 
difference between the instant at which Tref occurs and the instant at which the sinusoidal 
RA signal maximum or minimum occurs. Thus, a negative RAD value indicates the 
presence of early repolarization, which mostly involves the ST segment or the first half of 
the T wave. Instead, an RAD value close to zero indicates the presence of central RA, which 
mostly occurs over the T-wave apex. Eventually, a positive RAD value indicates the 
presence of late RA, characterized by the alternation of the final portion of the T wave. 
Within the same beat, the amplitude value of the sinusoidal RA signal provides an estimate 
of the RA amplitude (RAA, in µV).  
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Fig. 2. Block diagram describing the AMF-based procedure for characterization of RA in 
terms of RAA and RAD parameters.  
In the present study, RA analysis was initially performed in each ECG lead as follows. RAD 
and RAA values were first averaged over the 16 beats of each single-lead ECG segment 
(M16b_RAD_X and M16b_RAA_X, M16b_RAD_Y and M16b_RAA_Y, and M16b_RAD_Z 
and M16b_RAA_Z for leads X, Y, and Z, respectively); the resulting values were then 
averaged over the entire 5 minutes of each single-lead recording (M5m_RAD_X and 
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M5m_RAA_X, M5m_RAD_Y and M5m_RAA_Y, and M5m_RAD_Z and M5m_RAA_Z for 
leads X, Y, and Z, respectively). Eventually, the latter values were averaged over the three 
leads (M5m_RAD and M5m_RAA) for a comprehensive RA characterization relative to a 
single patient.  
 
Fig. 3. Simulated ECG tracing (solid lines) and relative RA signal (dotted lines) at the output 
of the heart-rate adaptive match filter (AMF) in the presence of early (panel A), central 
(panel B), and late (panel C) repolarization alternans.   
2.3 Definition of an RA normality region  
The M5m_RAD and M5m_RAA distributions over the CH population were used to identify 
an RA normality region delimited by three thresholds. Two of them (THR_RADmin and 
THR_RADmax) were defined for the M5m_RAD parameter as the 0.5th and the 99.5th 
percentiles of the M5m_RAD distribution, respectively. The third one (THR_RAA) was 
defined for the non-negative M5m_RAA parameter as the 99.5th percentile of the M5m_RAA 
distribution. A subject, independently of the belonging population, was classified as 
characterized by normal RA levels if the following conditions were simultaneously satisfied:  
 
5 _ _ min
5 _ _ max
5 _ _       
M m RAD THR RAD
M m RAD THR RAD
M m RAA THR RAA
  
 (2) 
These conditions define a physiologic RA region in the M5m_RAD vs. M5m_RAA plane 
(Fig. 4). Thus, no satisfaction of at least one condition denotes an abnormal RA case (RA+).  
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Fig. 4. Definition of a physiologic RA region in the M5m_RAD vs. M5m_RAA plane (shaded 
area in the upper panel). RA cases falling outside the physiologic RA region are considered 
abnormal RA cases (RA+). The ECG beat in the lower panel shows RA location along the JT 
interval.  
2.4 Statistics  
To be independent of normal distributions, non-parametric tests were used to perform 
comparisons among quantities. In the specific, comparisons between the distributions of the 
clinical and ECG parameters over the two populations (CAD vs. CH) were performed using 
the Wilcoxon rank sum test for equal medians. The Kruskal-Wallis test was used to perform 
the one-way ANOVA test to evaluate if, in a population, the RA parameters distributions 
over the three ECG leads were characterized by the same median value. Information about 
which pairs of leads had different median values was obtained using the multiple 
comparison procedure. The χ2 test was used to compare number of treated subjects between 
the two populations. Eventually, the existence of a possible relationship of the RA 
parameters with the clinical or the other ECG parameters was evaluated computing the 
correlation coefficient ρ. Statistical significance level was set at 5%. 
3. Results 
A summary of the clinical and ECG parameter values characterizing the CAD and the CH 
populations are reported in Table 1, where pharmaceutical treatments are also specified. 
Compared to the CH subjects, the CAD patients were significantly older and characterized 
by significantly higher BMI, SAP, and DAP, and by significantly lower heart rate (longer 
mRR) and heart-rate variability (lower sdRR).  
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CAD patients 
(201) 
CH subjects 
(167) 
P value 
Clinical  
parameters: 
  
 
Age (years) 58±11 38±15 <10-32 
BMI (kg/m2) 27±4 24±5 <10-13 
SAP (mmHg) 129±18 118±12 <10-11 
DAP (mmHg) 79±10 75±8 <10-3 
LVEF 58±11 NA - 
    
Treatments:    
Beta blocker 150 0 <0.005 
Digoxin 0 0 NS 
Diuretic 11 0 <0.01 
ACE inhibitor 57 0 <0.005 
Antiarrhythmic 6 0 NS 
    
ECG  
parameters: 
  
 
mRR (ms) 960±155 904±140 <10-3 
sdRR (ms) 37±40 43±24 <10-6 
M5m_RAD_X (ms) -29±52 -25±29 NS 
M5m_RAA_X (µV) 17±10 15±5 NS 
M5m_RAD_Y (ms) -34±51 -24±30 NS 
M5m_RAA_Y (µV) 21±12 20±8 NS 
M5m_RAD_Z (ms) -38±44 -32±31 NS 
M5m_RAA_Z (µV) 18±9 15±5 <10-3 
M5m_RAD(ms) -33±37 -27±23 NS 
M5m_RAA (µV) 19±9 17±15 <0.05 
Table 1. Clinical parameters, therapeutic treatments and ECG parameters relative to the 
CAD patients and the CH subjects. NA: not available; - : not applicable; NS: not significant. 
Some levels of RA were detected in all 201 CAD patients and 167 CH subjects. In both 
populations, RA amplitude values were significantly greater in lead Y (CAD: 
M5m_RAA_Y=21±12 µV; CH: M5m_RAA_Y=20±8 µV) than in leads X and Z (CAD: 
M5m_RAA_X=17±10 µV, M5m_RAA_Z=18±9 µV, P<10-5; CH: M5m_RAA_X=15±5 µV, 
M5m_RAA_Z=15±5 µV, P<10-9). Instead, comparable values of RA delay were measured 
over the leads in the CAD patients (M5m_RAD_X=-29±52 ms, M5m_RAD_Y=-34±51 ms, 
M5m_RAD_Z=-38±44 ms), while the CH subjects were characterized by a significantly 
lower RA delay value in lead Z (M5m_RAD_Z=-32±31 ms) compared to both lead X and Y 
(M5m_RAD_X=-25±29 ms, M5m_RAD_Y=-24±30 ms, P<0.01). Although RA amplitude 
appears systematically higher for the CAD patients than for the CH subjects in all leads, 
statistically significant differences were observed only in correspondence of lead Z 
(M5m_RAA_Z). No significant differences were found between the two populations in 
terms of RAD parameters, independently of the lead.  
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A comprehensive description of the RA phenomenon in the two populations was provided 
by M5m_RAA and M5m_RAD parameters. In the specific, the CAD population showed RA 
episodes characterized by higher amplitude (CAD M5m_RAA: 19±9 µV, CH M5m_RAA: 
17±5 µV, P<0.05; Table 1) and comparable delay (CAD M5m_RAD: -33±37 µV,  
CH M5m_RAD: -27±23 µV; Table 1). Still, M5m_RAD and M5m_RAA standard deviation 
values (Table 1) as well as the their distribution histograms (Fig. 5) indicate a greater 
M5m_RAD and M5m_RAA variability among the CAD patients than the CH subjects. 
According to these results, RA is localized over the first half of the T wave in most cases of 
the CH population, and only occasionally overcomes the T-wave apex. Instead, among the 
CAD patients, RA is distributed along the entire repolarization segment (ST/T wave), with 
several cases occurring over the ST segment or over the T-wave right-hand side. 
 
Fig. 5. Histograms of M5m_RAD and M5m_RAA distributions for the CAD (panels A and 
B) and CH (panels C and D) populations showing a greater M5m_RAD and M5m_RAA 
variability among the CAD patients than the CH subjects. 
The definition of an RA normality region (Fig. 6) delimited by THR_RADmin=-82 ms, 
THR_RADmax=28 ms, and THR_RAA=35 µV (as defined in Methods) allowed the 
identification of 29 (14.4%) RA+ CAD patients with abnormal M5m_RAD. Specifically, 22 
(10.9%) had abnormally low M5m_RAD (M5m_RAD <THR_RADmin) while the remaining 
7 (3.5%) had abnormally high M5m_RAD (M5m_RAD >THR_RADmax). RA+ CAD patients 
characterized by abnormally high M5m_RAA (M5m_RAA >THR_RAA) were 11 (5.5%). 
Among these, 4 were also characterized by abnormally low M5m_RAD. Thus, altogether, 36 
(17.9%) RA+ cases were identified among the CAD patients. By contrast, only 3 (1.8%) cases 
at the verge of abnormal condition were identified among the CH subjects (Fig. 6).  
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Correlative analysis showed that, in both CAD and CH populations, RA parameters 
distributions were not significantly linked to the other clinical and ECG (|ρ|≤0.44; Table 2) 
parameters distributions. Moreover, CAD patients under pharmaceutical treatments 
showed RA levels comparable to those characterizing not-treated patients (Table 3).  
 CAD patients 
(201) 
CH subjects 
(167) 
 M5m_RAD 
(ms) 
M5m_RAA (µV) M5m_RAD 
(ms) 
M5m_RAA 
(µV) 
Clinical 
parameters: 
    
Age (years) 0.11 -0.01 0.20* -0.28* 
BMI (kg/m2) 0.19* -0.10 -0.09 -0.30* 
SAP (mmHg) 0.11 -0.08 -0.06 -0.11 
DAP (mmHg) 0.16* -0.07 -0.11 -0.16* 
LVEF -0.17* 0.01 - - 
     
ECG  
parameters: 
    
mRR (ms) -0.44* 0.29* -0.42* 0.20* 
sdRR (ms) 0.00 0.10 -0.35* 0.39* 
Table 2. Correlation coefficient values linking RA parameters with the other clinical and 
ECG parameters. - : not applicable; *: statistically significant (P<0.05). 
 
Fig. 6. Representation of the RA cases for CH subjects (o) and the CAD patients (*) in 
relation to the RA normality region (internal solid-line square) in the M5m_RAD vs. 
M5m_RAA plane.  
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Table 3. Comparison of clinical and ECG parameteres between CAD patients under vs. not 
under pharmaceutical treatment. *: statistical signisficance (P<0.05) when comparing treated 
vs. not treated CAD patients groups.  
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4. Discussion 
Our study represents the first attempt to quantify RA heterogeneity in the coronary artery 
disease (CAD) in terms of the traditional RA amplitude as it combines with a temporal 
parameter that allows RA localization along the JT segment as a delay from the T-wave 
apex. This characterization was accomplished by analyzing RA in 5-minute resting ECG 
recordings by means of our AMF-based technique, previously tested for T-wave alternans 
detection and quantification in both simulated and clinical settings (Burattini et al., 2006, 
Burattini et al., 2008, Burattini et al., 2009a, Burattini et al., 2009b, Burattini et al., 2010, 
Burattini et al., 2011). 
Previous studies reported by others identified temporal RA localization in cases other than 
CAD, either by computing the time-interval from the R peak to the RA instant of occurrence 
(Martínez et al., 2006, Nearing et al., 1994, Selvaraj et al., 2007) or by identifying three 
windows of half JT duration (localized at the beginning, at the middle and at the end of 
repolarization, respectively) and, subsequently, determining which of these was more 
affected by RA (Narayan & Smith, 1999). The former approach has the major limitation of 
not taking into account the physiological variability of the RR interval and the JT duration, 
so that the same time interval localizing RA can be associated to different alternating 
portions of the JT segment. The latter approach tries to overcome this limitation by use of 
three windows half-overlapped. However, because of the large variability characterizing the 
ST segment in clinical cases, the middle window does not necessarily include the T-wave 
apex, as it is expected to do. Our AMF-based approach resolves these limitations by 
measuring the “delay” (RAD) of the alternans with respect to the T-wave apex, so that large 
negative values of RAD are necessarily due to RA occurring along the ST segment and the 
T-wave left-hand side. Instead, RAD values close to zero indicate the presence of RA mainly 
localized over the T wave, while positive values of RAD indicate alternation of the T-wave 
right-hand side. Since each portion of the JT segment pertains to a specific phase of the 
ventricular repolarization, our AMF-based method is expected to provide a more accurate 
identification of the ventricular repolarization phase involved in the alternation.  
Besides RA heterogeneity characterization, our AMF-based method has the further 
peculiarity of relying on the RA continuity hypothesis. Other techniques, such as the 
spectral method, the RA identification technique most commonly used in clinics (Smith et 
al., 1988, Rosenbaum et al., 1994, Rosenbaum et al., 1996), and the Laplacian likelihood ratio 
method (Martínez & Olmos, 2005, Martínez et al., 2006) ascribe to noise the low-TWA levels, 
not associated with cardiac instability, which are even detected under physiological 
conditions. This methodological approach aroused from the early hypothesis that RA could 
be an on–off phenomenon, usually not present in health (Bloomfield et al., 2002). After the 
recent experimental study by Pruvot et al.(Pruvot et al., 2004) who demonstrated the 
possibility of inducing various levels of RA, some of which not necessarily associated to 
cardiac instability, the hypothesis that RA is a phenomenon characterized by a continuously 
changing amplitude and/or location from physiological to pathological condition has 
gained increasing consideration. This assumption requires the set up of methods, like our 
AMF-based one, that allow identification of an RA normality region to improve reliability in 
the discrimination of non-physiological or abnormal RA (RA+) levels potentially at risk of 
cardiac instability. In the present study the RA normality region was delimited by three 
thresholds (THR_RADmin, THR_RADmax, THR_RAA, respectively), computed from the 
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RA parameters distribution over the CH population (Burattini et al., 2008, Burattini et al., 
2009a). More specifically, THR_RADmin and THR_RADmax were defined as the 0.5th and 
99.5th percentiles of the M5m_RAD distribution, whereas one other threshold was defined as 
the 99.5th percentile over the THR_RAA distribution, being it a non-negative parameter. Use 
of percentiles, rather than mean and SD, makes the procedure independent of the 
assumption of normal distribution for parameter estimates. These threshold definitions 
strongly optimize specificity rather than sensitivity. The rationale for our choice is that, as 
mentioned above, RA was initially supposed not be present in healthy conditions 
(Bloomfield, 2002), so that the number of positive detections among healthy subjects was 
forced to be negligible (Burattini et al., 2008). Due to our recent studies highlighting the 
hypothesis that RA is a phenomenon characterized by an amplitude continuously changing 
from physiological to abnormal conditions (Burattini et al., 2009a, Burattini et al., 2010), 
identification of thresholds levels at 0.5th and 99.5th percentile may be too restrictive and, 
thus, not appropriate for an optimal identification of abnormal RA cases. Optimization of 
thresholds for RA+ identification in relation to risk stratification, however, is beyond the 
scope of this work, which is mainly focused on RA characterization in the coronary artery 
disease. 
With this aim, our AMF-based technique was applied to ECG tracings from CAD patients, 
who, compared to CH subjects, are known to show increased levels of T-wave alternans 
(Bigger & Bloomfield, 2007, Bloomfield et al., 2006, Burattini et al., 2009a, Burattini et al., 
2010, Ikeda et al., 2006, Zacks et al., 2007) and to be prone to experience major cardiac 
events related to it (Narayan et al., 2006). Our results indicate that, in agreement with 
what previously found (Burattini et al., 2008, Burattini et al., 2009a, Burattini et al., 2010), 
RA affects all subjects, either diseased or healthy, with different characteristics though. 
First of all, the CAD patients were, on average, characterized by higher RA amplitude 
than the CH subjects ( CAD: 19±9 µV, CH: 17±15 µV; P<0.05). The most interesting results, 
however, concern the RA localization, which was distributed all over the entire JT 
segment (ST segment, or T-wave left-hand side, or T-wave right-hand side) in the CAD 
patients, whereas it occurred mainly over the T-wave left-hand side, and occasionally in 
correspondence of the T-wave apex, among the CH subjects. Similarly to our CAD 
patients, RA was found to be distributed all along the JT segment also in the 
cardiomyopathy (Selvaraj et al., 2007). In spite of the fact that our choice of the threshold 
values delimiting the RA normality region tends to minimize the number of RA+ cases, 
the greater RA heterogeneity observed in our CAD patients compared with CH subjects 
allowed discrimination of a relevant percentage (17.9%) of RA+ cases in the coronary 
artery disease (Fig. 6). In these abnormal cases RA was characterized by high amplitude 
(5.5%), as previously reported in other studies on the CAD (Narayan et al., 2006), or 
occurred either early (11.0%), as in other diseased states (Martínez et al., 2006, Nearing et 
al., 1994), or late (3.5%) along the JT segment. According to Narayan & Smith (1999), RA 
occurring late is mainly associated to ventricular tachycardia. Thus, the characterization 
of RA in terms of both RA amplitude (generally used to discriminate RA+ cases in most 
studies using other techniques) and RA delay (a parameters which instead is a peculiarity 
of our AMF-based method) allowed a significant increment in the identification of RA+ 
cases among the CAD patients, which raised from 11 (identified when using only the RA 
amplitude parameter) to 36.  
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According to our results, increased RA heterogeneity observed in the CAD population was 
not associated to other clinical factors (age, BMI, SAP, DAP and LVEF) or pharmaceutical 
treatments (beta blocker, digoxin, diuretic, and ACE inhibitor), with the only exception of 
heart rate. Indeed, a significant, though low (-0.44≤ρ≤-0.42; P<0.05), correlation was found 
between M5m_RAD and RR in both populations, indicating that early RA tends to 
characterize patients with prolonged RR. Instead, a negligible correlation (0.20≤ρ≤0.29, 
P<0.05) was found between M5m_RAA and RR distributions. This result is complementary 
and not in contradiction with the findings from several other studies, which have previously 
related RA amplitude to hart rate (Bloomfield et al., 2002, Narayan & Smith, 1999, Narayan 
& Smith, 2000, Smith et al., 1988). Such studies have indeed demonstrated that, within a 
subject, RA increases when heart rate is forced to increase (by pacing, exercise or drug) over 
90 beats/min (Bloomfield et al., 2002). Identification of RA at rest, as in the present study, 
was often neglected because it requires sophisticated RA identification methods, such as our 
AMF-based one (Burattini et al., 2011), suitable to detect low levels of RA even in the 
presence of physiological levels of heart-rate variability (heart-rate variability is indeed 
strongly reduced at high heart rates).  
5. Conclusion 
Our quantitative investigation of RA heterogeneity in CAD patients yields the conclusion 
that, compared to the CH subjects, the former population shows higher RA amplitude and 
greater variability of RA localization along the JT segment. Especially, in the coronary artery 
disease, the RA occurs not only over the left-hand side of the T wave, as it is generally 
observed in health, but also along the ST segment (early repolarization) or along the T-wave 
right-hand side (late repolarization). Identification of patients characterized by RA occurring 
in early or late repolarization is relevant since in the literature these kinds of RA phenomena 
are associated to an increased risk of ventricular arrhythmias. Thus, our AMF-based  
method appears as a useful tool to identify RA characteristics that help enhancing 
pathophysiological interpretation and, with it, the ability to discriminate patients at 
increased risk of sudden cardiac death, who might be appropriately treated before they 
experience a major cardiac event. 
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